Aclarion adds University of Arizona College of Medicine–Phoenix as CLARITY trial site for Nociscan

PUBT · 1d ago
Aclarion adds University of Arizona College of Medicine–Phoenix as CLARITY trial site for Nociscan
  • Aclarion added University of Arizona College of Medicine – Phoenix as a new enrolling site for its CLARITY spine-surgery trial.
  • The 300-patient, randomized study tests whether Nociscan improves outcomes in discogenic chronic low back pain surgeries.
  • No results have been presented; early interim findings are expected to be publicly disclosed in Q4 2026.
  • The trial aims to support broader adoption of Nociscan for surgical decision-making by improving patient selection and reducing avoidable procedures.
  • Ten sites are now enrolling, expanding recruitment capacity and potentially accelerating the timeline to clinically meaningful readouts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200700PRIMZONEFULLFEED9813246) on August 20, 2026, and is solely responsible for the information contained therein.